Search Results for 'arv hiv'

arv hiv published presentations and documents on DocSlides.

Global Price Reporting Mechanism (GPRM); ARV Drug Regulatory Status  Database  (DRS); ARV Active Ph
Global Price Reporting Mechanism (GPRM); ARV Drug Regulatory Status Database (DRS); ARV Active Ph
by luanne-stotts
relevance and options for the future. B. Dongmo N...
ARV Procurement and Value For Money
ARV Procurement and Value For Money
by marina-yarberry
Cameroon Perspectives . IAS, Paris 23 July, . 201...
Eliminating Perinatal HIV Transmission
Eliminating Perinatal HIV Transmission
by jane-oiler
A Curriculum for OB/GYN Resident and Midwifery Pr...
Newborn born  TO hiv ( )
Newborn born TO hiv ( )
by test
mother. ID weekly conferences. Gouri Scheurmann ....
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines
by stefany-barnette
Treatment Recommendations for Pregnant and Breast...
Song 1 intro
Song 1 intro
by lucinda
1 J i v i n g w i t h S c i e n c e C D 1 E n g l ...
ARVs & DDIs in pregnancy
ARVs & DDIs in pregnancy
by obrien
Scientific Workshop. Improving patient care throug...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
Viral Load Monitoring and Enhanced
Viral Load Monitoring and Enhanced
by esther
Adherence. Counseling. Flipchart. Adults, non-preg...
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
by myesha-ticknor
Clinical aspects of ADRs in HIV and ARV toxicity ...
“Getting to Zero:  Thailand’s
“Getting to Zero: Thailand’s
by aaron
Experience with E-MTCT”. Petchsri. . Sirinirun...
New Directions in the 2015  Consolidated ARV Guidelines Update
New Directions in the 2015 Consolidated ARV Guidelines Update
by test
Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Sa...
Ulwazi   malunga   nokungasebenzi
Ulwazi malunga nokungasebenzi
by marina-yarberry
(. kwamayeza. ) e HIV. Kukuthini. . ukungeva. ?...
Assoc.Prof
Assoc.Prof
by yoshiko-marsland
. . Thanyawee. . Puthanakit. , MD.. Division of ...
ARVs
ARVs
by alexa-scheidler
do not get rid of HIV from the body – they stop...
Scaling up what works: replicating models on community serv
Scaling up what works: replicating models on community serv
by yoshiko-marsland
Jennifer Gatsi Mallet. Namibia Women’s Health N...
FINANCING ARV
FINANCING ARV
by tatiana-dople
EXPERIENCE FROM MALAYSIA. BY. SHA’ARI NGADIMAN,...
High-dose rifampicin
High-dose rifampicin
by pasty-toler
TB treatment regimen to . reduce . 12-month . mor...
Promoting Adherence and Retention in ARV-based Prevention
Promoting Adherence and Retention in ARV-based Prevention
by briana-ranney
Dr. Seema Sahay, Ph.D. Division of Social and Beh...
The Future of HIV Treatment
The Future of HIV Treatment
by myesha-ticknor
Greg Perry. Melbourne – International AIDS Conf...
Cancer in HIV Patients in Latin America and the Caribbean:
Cancer in HIV Patients in Latin America and the Caribbean:
by SugarLips
Characteristics in seven sites from the . CCASAnet...
CROI 2019:  ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
 The ART of HIV Management:
The ART of HIV Management:
by briana-ranney
An Antiretroviral Therapy Review. Sarah Pérez, P...
Potential safety issue affecting women living with HIV using
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Diagnosis and Initial Management of HIV/AIDS:
Diagnosis and Initial Management of HIV/AIDS:
by cheryl-pisano
What the Primary Care Provider Should Know. Carol...
What Happens to HIV Programs When Donors Leave?
What Happens to HIV Programs When Donors Leave?
by luanne-stotts
. The GFATM procurement cliff. Sharonann Lynch. ...
Perinatal HIV Transmission Prevention
Perinatal HIV Transmission Prevention
by sherrill-nordquist
Missed Opportunities. Ryan White 2012 Conference....
Adolescent HIV Care and Treatment
Adolescent HIV Care and Treatment
by tatiana-dople
Module 11:. Family Planning and PMTCT Services fo...
The Kabeho  Study*:  Kigali
The Kabeho Study*: Kigali
by phoebe-click
Antiretroviral and Breastfeeding Assessment for t...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
Basic principles of DDIs with ARVs: an introduction  David Back
Basic principles of DDIs with ARVs: an introduction David Back
by marina-yarberry
Basic principles of DDIs with ARVs: an introducti...
Non-ARV  Based Interventions to Combat
Non-ARV Based Interventions to Combat
by tatiana-dople
Non-ARV Based Interventions to Combat HIV/AIDS:...
 New Directions in  the future 2015
New Directions in the future 2015
by mitsue-stanley
Consolidated ARV Guidelines Update. Meg . Doherty...
Kebijakan  Program  Pencegahan
Kebijakan Program Pencegahan
by blondiental
dan . Pengendalian . HIV . AIDS . dan. . PIMS. K...
ARV Resistance  1 Learning Objectives
ARV Resistance 1 Learning Objectives
by naomi
Define drug resistance. Identify . factors that in...
Cases From the Clinic( ians
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
CNS  pharmacology   of  antiretroviral
CNS pharmacology of antiretroviral
by PlayfulSpirit
drugs. . and. relevant . interactions. . betwee...
New drugs for individuals
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
29% abnormal scores   in
29% abnormal scores in
by Thrillseeker
screening for . depression and anxiety. All 26 ado...